TY - JOUR
KW - Clinical Trials as Topic
KW - Dapsone
KW - Dose-Response Relationship, Drug
KW - Humans
KW - leprosy
BT - Lancet (London, England)
C1 - http://www.ncbi.nlm.nih.gov/pubmed/63682?dopt=Abstract
DA - 1977 Jan 01
IS - 8001
J2 - Lancet
LA - eng
PY - 1977
SP - 44
EP - 5
T2 - Lancet (London, England)
TI - Borderline leprosy reactions and dapsone.
VL - 1
SN - 0140-6736
ER -